Verified Nov 2026
Batteries & E-Mobility
·

Oxford, England
·
Since 1995
Oxford Biomedica is a contract development and manufacturing organization (CDMO) headquartered in Oxford, England, founded in 1995. The company employs 1,000–5,000 people and specializes in cell and gene therapy manufacturing, including viral vector development using proprietary LentiVector and inAAVate platforms. It serves pharmaceutical, biotech, oncology, and advanced therapy sectors across facilities in the UK, France, and the USA.
Oxford Biomedica at a glance
Revenue
$50-100M
Est. band
Employees
1,000-5,000
Founded
1995
Headquarters
Oxford, England
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Oxford Biomedica is a contract development and manufacturing organization (CDMO) headquartered in Oxford, England, founded in 1995. The company employs 1,000–5,000 people and specializes in cell and gene therapy manufacturing, including viral vector development using proprietary LentiVector and inAAVate platforms. It serves pharmaceutical, biotech, oncology, and advanced therapy sectors across facilities in the UK, France, and the USA.
At a glance
Attribute | Detail |
|---|---|
Founded | 1995 |
Headquarters | Oxford, England |
Employees | 1,000-5,000 |
Revenue | $50-100M (estimated) |
Primary capability | Batteries & E-Mobility |
What Oxford Biomedica makes
Oxford Biomedica provides viral vector process development, GMP manufacturing, and bioprocessing support using advanced platform technologies for various therapy areas including oncology, ophthalmology, and central nervous system disorders.
Products and capabilities described on the company's own site include LED, Suspension (source: oxb.com).
Latest developments
2026-09-22 — Oxford Biomedica PLC Interim results for the six months ended 30 June 2026 - OXB (oxb.com)
2026-07-16 — Manufacturing agreement with Plowshare Therapies | Company Announcement | Investegate (investegate.co.uk)
2026-04-13 — This is Money (thisismoney.co.uk)
2026-03-26 — Preliminary results for the year ended 31 December 2025 (oxb.com)
2026-03-18 — Oxford Biomedica Signs Licensing Deal with Australia’s VVMF | Contract Pharma (contractpharma.com)
2026-02-04 — Multi-year supply agreement with BMS | Company Announcement | Investegate (investegate.co.uk)
Facilities
Oxford Biomedica is headquartered in Oxford, England. Public sources also reference these locations:
Oxford, UK — investegate.co.uk
Durham, NC — oxb.com
Company details
The company is publicly listed on the London Stock Exchange and included in the FTSE 250 Index, serving global biopharma and pharmaceutical organizations. Oxford Biomedica was founded in 1995, has an estimated 1,000-5,000 employees, and is headquartered in Oxford, England.
Frequently asked questions
What does Oxford Biomedica make?
Oxford Biomedica is a contract development and manufacturing organization (CDMO) headquartered in Oxford, England, founded in 1995. The company employs 1,000–5,000 people and specializes in cell and gene therapy manufacturing, including viral vector development using proprietary LentiVector and inAAVate platforms. It serves pharmaceutical, biotech, oncology, and advanced therapy sectors across facilities in the UK, France, and the USA.
Where is Oxford Biomedica headquartered?
Oxford Biomedica is headquartered in Oxford, England (Transport Way, Oxford, England, OX4 6).
When was Oxford Biomedica founded?
Oxford Biomedica was founded in 1995.
How big is Oxford Biomedica?
Oxford Biomedica has an estimated 1,000-5,000 employees, with revenue in the $50-100M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
